Search for stock quotes, financial statistics and more
Research Capital analyst Andre Uddin maintained his “Speculative Buy” rating and C$3.50 price ta... Read More
Research Capital analyst André Uddin re-initiated coverage of Spectral Medical (Spectral Medical St... Read More
Paradigm Capital analyst Scott McAuley said in an Aug. 25 note that Spectral Medical (Spectral Medic... Read More
Paradigm Capital analyst Scott McAuley is maintaining a “Buy” rating and $2.30 target on... Read More
Paradigm Capital analyst Scott McAuley likes what he sees in clinical stage medical device company S... Read More
Share
Tweet
pin
Share